•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

S07900 Summary:

BILL NOS07900
 
SAME ASSAME AS A08136
 
SPONSORBAILEY
 
COSPNSR
 
MLTSPNSR
 
Amd §§3216, 3221 & 4303, Ins L; amd §4406-c, Pub Health L
 
Authorizes insurance policies which provide coverage for prescription drugs where cost-sharing obligations are determined by category of prescription drugs to offer a program to insureds that utilizes rebates or discounts to lower an insured's cost-sharing for prescription drugs if the insured's cost-sharing under such program would be more favorable than the cost-sharing that would otherwise be applicable to the prescription drug.
Go to top

S07900 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          7900
 
                               2025-2026 Regular Sessions
 
                    IN SENATE
 
                                      May 13, 2025
                                       ___________
 
        Introduced  by  Sen.  BAILEY -- read twice and ordered printed, and when
          printed to be committed to the Committee on Insurance
 
        AN ACT to amend the insurance law and the public health law, in relation
          to  authorizing  insurance  policies  which   provide   coverage   for
          prescription  drugs  and  involve  cost-sharing obligations to offer a
          program to insureds utilizing rebates or discounts
 
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section  1.  Paragraph  27  of  subsection  (i) of section 3216 of the
     2  insurance law, as added by chapter 536 of the laws of 2010,  is  amended
     3  to read as follows:
     4    (27)  (A)  No  policy  delivered  or issued for delivery in this state
     5  which provides coverage for prescription drugs and for which  cost-shar-
     6  ing,  deductibles or co-insurance obligations are determined by category
     7  of prescription drugs shall impose cost-sharing, deductibles or co-insu-
     8  rance obligations for any prescription  drug  that  exceeds  the  dollar
     9  amount  of  cost-sharing,  deductibles  or  co-insurance obligations for
    10  non-preferred brand drugs or its equivalent (or brand drugs if there  is
    11  no non-preferred brand drug category).
    12    (B)  Notwithstanding the limitations prescribed in subparagraph (A) of
    13  this paragraph or any other provision of  law,  a  policy  delivered  or
    14  issued   for   delivery  in  this  state  which  provides  coverage  for
    15  prescription drugs where  cost-sharing  obligations  are  determined  by
    16  category  of  prescription  drugs  may  offer a program to insureds that
    17  utilizes rebates or discounts to lower  an  insured's  cost-sharing  for
    18  prescription  drugs  if  the  insured's  cost-sharing under such program
    19  would be more favorable than the cost-sharing that  would  otherwise  be
    20  applicable  to the prescription drug. A program offered pursuant to this
    21  subparagraph shall not be deemed a separate tier of drug cost-sharing. A
    22  description of the program shall be set forth in the policy or contract,
    23  provided, however, such description may refer insureds to a website  for
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD11644-01-5

        S. 7900                             2
 
     1  additional   information,  including  details  regarding  the  insured's
     2  reduced cost-sharing.
     3    §  2.  Paragraph 16 of subsection (a) of section 3221 of the insurance
     4  law, as added by chapter 536 of the laws of 2010, is amended to read  as
     5  follows:
     6    (16)  (A)  No  policy  delivered  or issued for delivery in this state
     7  which provides coverage for prescription drugs and for which  cost-shar-
     8  ing,  deductibles or co-insurance obligations are determined by category
     9  of prescription drugs shall impose cost-sharing, deductibles or co-insu-
    10  rance obligations for any prescription  drug  that  exceeds  the  dollar
    11  amount  of  cost-sharing,  deductibles  or  co-insurance obligations for
    12  non-preferred brand drugs or its equivalent (or brand drugs if there  is
    13  no non-preferred brand drug category).
    14    (B)  Notwithstanding the limitations prescribed in subparagraph (A) of
    15  this paragraph or any other provision of  law,  a  policy  delivered  or
    16  issued   for   delivery  in  this  state  which  provides  coverage  for
    17  prescription drugs where  cost-sharing  obligations  are  determined  by
    18  category  of  prescription  drugs  may  offer a program to insureds that
    19  utilizes rebates or discounts to lower  an  insured's  cost-sharing  for
    20  prescription  drugs  if  the  insured's  cost-sharing under such program
    21  would be more favorable than the cost-sharing that  would  otherwise  be
    22  applicable  to the prescription drug. A program offered pursuant to this
    23  subparagraph shall not be deemed a separate tier of drug cost-sharing. A
    24  description of the program shall be set forth in the policy or contract,
    25  provided, however, such description may refer insureds to a website  for
    26  additional   information,  including  details  regarding  the  insured's
    27  reduced cost-sharing.
    28    § 3. Subsection (jj) of section 4303 of the insurance law, as added by
    29  chapter 536 of the laws of 2010 and as relettered by section 55 of  part
    30  D of chapter 56 of the laws of 2013, is amended to read as follows:
    31    (jj)  (1) No medical expense indemnity corporation, a hospital service
    32  corporation or a health service corporation which provides coverage  for
    33  prescription  drugs  and for which cost-sharing, deductibles or co-insu-
    34  rance obligations are determined by category of prescription drugs shall
    35  impose cost-sharing, deductibles or  co-insurance  obligations  for  any
    36  prescription drug that exceeds the dollar amount of cost-sharing, deduc-
    37  tibles  or co-insurance obligations for non-preferred brand drugs or its
    38  equivalent (or brand drugs if there is no non-preferred brand drug cate-
    39  gory).
    40    (2) Notwithstanding the limitations prescribed  in  paragraph  one  of
    41  this  subsection or any other provision of law, a medical expense indem-
    42  nity corporation, a hospital service corporation  or  a  health  service
    43  corporation  which  provides coverage for prescription drugs where cost-
    44  sharing obligations are determined by category of prescription drugs may
    45  offer a program to insureds that utilizes rebates or discounts to  lower
    46  an  insured's cost-sharing for prescription drugs if the insured's cost-
    47  sharing under such program would be more favorable than the cost-sharing
    48  that would otherwise be applicable to the prescription drug.  A  program
    49  offered  pursuant  to this paragraph shall not be deemed a separate tier
    50  of drug cost-sharing. A description of the program shall be set forth in
    51  the policy or contract, provided, however, such  description  may  refer
    52  insureds  to  a  website  for  additional information, including details
    53  regarding the insured's reduced cost-sharing.
    54    § 4. Subdivision 7 of section 4406-c of  the  public  health  law,  as
    55  added by chapter 536 of the laws of 2010, is amended to read as follows:

        S. 7900                             3
 
     1    7.  (a) No health maintenance organization which provides coverage for
     2  prescription drugs and for which cost-sharing, deductibles  or  co-insu-
     3  rance obligations are determined by category of prescription drugs shall
     4  impose  cost-sharing,  deductibles  or  co-insurance obligations for any
     5  prescription drug that exceeds the dollar amount of cost-sharing, deduc-
     6  tibles  or co-insurance obligations for non-preferred brand drugs or its
     7  equivalent (or brand drugs if there is no non-preferred brand drug cate-
     8  gory).
     9    (b) Notwithstanding the limitations prescribed  in  paragraph  (a)  of
    10  this  subdivision  or  any  other provision of law, a health maintenance
    11  organization which provides coverage for prescription drugs where  cost-
    12  sharing obligations are determined by category of prescription drugs may
    13  offer a program to enrollees that utilizes rebates or discounts to lower
    14  an  enrollee's  cost-sharing  for  prescription  drugs if the enrollee's
    15  cost-sharing under such program would be more favorable than  the  cost-
    16  sharing  that would otherwise be applicable to the prescription drug.  A
    17  program offered pursuant to this paragraph shall not be deemed  a  sepa-
    18  rate  tier  of  drug cost-sharing. A description of the program shall be
    19  set forth in the policy or contract, provided, however, such description
    20  may refer enrollees to a website for additional  information,  including
    21  details regarding the enrollee's reduced cost-sharing.
    22    §  5.  This  act  shall take effect January 1, 2026 and shall apply to
    23  policies or contracts issued, renewed, modified, altered or  amended  on
    24  or after such date.
Go to top